Made for this

Where your product & our expertise go further.

At Simtra BioPharma Solutions, we’re made for this.  With 65+ years of sterile injectable manufacturing experience, we bring precision and transparency to every step of the production process, from product development through commercial fill and finish. As a premier independent CDMO, we partner with pharmaceutical and biotech companies to help them realize their commercialization objectives for sterile injectables.

Whether you are looking to launch your innovation globally, improve your formulation, or proactively mitigate risk, Simtra can help you deliver on your commitments to patients.

©  2025 Simtra BioPharma Solutions. Any other trademarks, product brands or images appearing here in are the property of their respective owners. 02/25

Go to article: Home | Are European biopharma manufacturers ‘nearshoring’?Go to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: MilliporeSigmaGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: Frewitt Company InsightGo to article: In DepthGo to article: Are European biopharma manufacturers ‘nearshoring’?Go to article: Inborn errors of metabolism elicit unique challenges for therapy developmentGo to article: GLP-1RAs and opioid use disorder: a new frontier in addiction treatmentGo to article: European agencies catch up with speedier regulatory pathways for CGTs in the USGo to article: USAID funding fallout: sponsors, and agencies may have to fill funding gapGo to article: Pfizer’s bet on gene therapies in haemophilia has been a bustGo to article: SimtraGo to article: Zenatek Company InsightGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Buyer's GuidesGo to article: Next issue